Tech Company Financing Transactions
TearOptix Funding Round
TearOptix closed a funding round on 11/17/2025. Investors included private investors.
Transaction Overview
Company Name
Announced On
11/17/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
801 Hermosa Way
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
TearOptix, Inc. is redefining presbyopia correction with its proprietary tear- and blink-responsive contact lens technology, delivering exceptional clarity, comfort, and natural vision at all distances. Headquartered in Silicon Valley, the company merges breakthrough optical engineering with world-class clinical expertise to set a new standard in vision care. TearOptix is committed to transforming the lives of millions affected by age-related vision changes through innovation that bridges science and human experience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vartan Ghazarossian
Browse more venture capital transactions:
Prev: 11/17/2025: Ghanem venture capital transaction
Next: 11/17/2025: T-Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs